Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 3/2013

01.03.2013 | Review Article

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

verfasst von: Henning Dralle, Thomas J. Musholt, Jochen Schabram, Thomas Steinmüller, Andreja Frilling, Dietmar Simon, Peter E. Goretzki, Bruno Niederle, Christian Scheuba, Thomas Clerici, Michael Hermann, Jochen Kußmann, Kerstin Lorenz, Christoph Nies, Peter Schabram, Arnold Trupka, Andreas Zielke, Wolfram Karges, Markus Luster, Kurt W. Schmid, Dirk Vordermark, Hans-Joachim Schmoll, Reinhard Mühlenberg, Otmar Schober, Harald Rimmele, Andreas Machens, for the German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V.

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Over the past years, the incidence of thyroid cancer has surged not only in Germany but also in other countries of the Western hemisphere. This surge was first and foremost due to an increase of prognostically favorable (“low risk”) papillary thyroid microcarcinomas, for which limited surgical procedures are often sufficient without loss of oncological benefit. These developments called for an update of the previous practice guideline to detail the surgical treatment options that are available for the various disease entities and tumor stages.

Methods

The present German Association of Endocrine Surgeons practice guideline was developed on the basis of clinical evidence considering current national and international treatment recommendations through a formal expert consensus process in collaboration with the German Societies of General and Visceral Surgery, Endocrinology, Nuclear Medicine, Pathology, Radiooncology, Oncological Hematology, and a German thyroid cancer patient support organization.

Results

The practice guideline for the surgical management of malignant thyroid tumors includes recommendations regarding preoperative workup; classification of locoregional nodes and terminology of surgical procedures; frequency, clinical, and histopathological features of occult and clinically apparent papillary, follicular, poorly differentiated, undifferentiated, and sporadic and hereditary medullary thyroid cancers, thyroid lymphoma and thyroid metastases from primaries outside the thyroid gland; extent of thyroidectomy; extent of lymph node dissection; aerodigestive tract resection; postoperative follow-up and surgery for recurrence and distant metastases.

Conclusion

These evidence-based recommendations for surgical therapy reflect various “treatment corridors” that are best discussed within multidisciplinary teams and the patient considering tumor type, stage, progression, and inherent surgical risk.
Literatur
1.
Zurück zum Zitat Robert Koch Institut (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends 6. In: Robert Koch Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (eds) Lübeck, 6th revised edition, Berlin, p 86–89, German Robert Koch Institut (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends 6. In: Robert Koch Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (eds) Lübeck, 6th revised edition, Berlin, p 86–89, German
2.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) WHO classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon, pp 49–133 DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) WHO classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon, pp 49–133
3.
Zurück zum Zitat Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1972–2002. JAMA 295:2164–2167 Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1972–2002. JAMA 295:2164–2167
4.
Zurück zum Zitat Hughes DT, Haymart MR, Miller BS et al (2011) The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231–236PubMedCrossRef Hughes DT, Haymart MR, Miller BS et al (2011) The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231–236PubMedCrossRef
5.
Zurück zum Zitat Aschebrook-Kilfoy B, Ward MH, Sabra MM et al (2011) Thyroid cancer incidence patterns in the United States by histology type, 1992–2006. Thyroid 21:125–134PubMedCrossRef Aschebrook-Kilfoy B, Ward MH, Sabra MM et al (2011) Thyroid cancer incidence patterns in the United States by histology type, 1992–2006. Thyroid 21:125–134PubMedCrossRef
6.
Zurück zum Zitat Lise M, Franceschi S, Buzzoni C et al (2012) Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid 22:27–34PubMedCrossRef Lise M, Franceschi S, Buzzoni C et al (2012) Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid 22:27–34PubMedCrossRef
7.
Zurück zum Zitat Dralle H (2008) Maligne Schilddrüsentumoren. In: Deutsche Krebsgesellschaft (ed) Kurzgefaßte interdisziplinäre Leitlinien. W. Zuckschwerdt, München, German Dralle H (2008) Maligne Schilddrüsentumoren. In: Deutsche Krebsgesellschaft (ed) Kurzgefaßte interdisziplinäre Leitlinien. W. Zuckschwerdt, München, German
8.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyorid cancer. Thyroid 19:1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyorid cancer. Thyroid 19:1167–1214PubMedCrossRef
9.
Zurück zum Zitat Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612PubMedCrossRef Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612PubMedCrossRef
11.
Zurück zum Zitat Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803PubMedCrossRef Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803PubMedCrossRef
12.
Zurück zum Zitat Dutch association of comprehensive cancer centres thyroid cancer (2007) National evidence-based guideline, version 1.0. http://www.oncoline.nl. Accessed 2 December 2012 Dutch association of comprehensive cancer centres thyroid cancer (2007) National evidence-based guideline, version 1.0. http://​www.​oncoline.​nl. Accessed 2 December 2012
13.
Zurück zum Zitat Luster M, Clarke SE, Dietlein M et al (2008) Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941–1959PubMedCrossRef Luster M, Clarke SE, Dietlein M et al (2008) Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941–1959PubMedCrossRef
14.
Zurück zum Zitat Dietlein M, Dressler J, Eschner W et al (2007) Verfahrensanweisung zur Radioiodtherapie (RIT) beim differenzierten Schilddrüsenkarzinom (version 3). Nuklearmedizin 46:213–219, GermanPubMed Dietlein M, Dressler J, Eschner W et al (2007) Verfahrensanweisung zur Radioiodtherapie (RIT) beim differenzierten Schilddrüsenkarzinom (version 3). Nuklearmedizin 46:213–219, GermanPubMed
15.
Zurück zum Zitat Takami H, Ito Y, Okamoto T et al (2011) Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 35:111–121PubMedCrossRef Takami H, Ito Y, Okamoto T et al (2011) Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 35:111–121PubMedCrossRef
16.
Zurück zum Zitat Carling T, Carty SE, Ciarleglio MM et al (2012) American Thyroid Association Surgical Affairs Committee. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 3:237–244CrossRef Carling T, Carty SE, Ciarleglio MM et al (2012) American Thyroid Association Surgical Affairs Committee. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 3:237–244CrossRef
17.
Zurück zum Zitat Carty SE, Doherty GM, Inabnet WB III et al (2012) American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid 22:395–399PubMedCrossRef Carty SE, Doherty GM, Inabnet WB III et al (2012) American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid 22:395–399PubMedCrossRef
18.
Zurück zum Zitat Wittekind C, Meyer JH (2010) TNM Klassifikation maligner Tumoren, 7. Auflage. Wiley-VCH, Weinheim, pp 55–59, German Wittekind C, Meyer JH (2010) TNM Klassifikation maligner Tumoren, 7. Auflage. Wiley-VCH, Weinheim, pp 55–59, German
19.
Zurück zum Zitat Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028, GermanPubMedCrossRef Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028, GermanPubMedCrossRef
20.
Zurück zum Zitat Kelz RR, Fraker DL (2005) Factors that predispose to thyroid neoplasia. In: Clark O, Duh CY, Kebebew E (eds) Textbook of endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 240–247CrossRef Kelz RR, Fraker DL (2005) Factors that predispose to thyroid neoplasia. In: Clark O, Duh CY, Kebebew E (eds) Textbook of endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 240–247CrossRef
21.
Zurück zum Zitat Morris LF, Ragavendra N, Yeh MW (2008) Evidence-based assessment of the role of ultrasonography in the management of benign thyroid nodules. World J Surg 32:1253–1263PubMedCrossRef Morris LF, Ragavendra N, Yeh MW (2008) Evidence-based assessment of the role of ultrasonography in the management of benign thyroid nodules. World J Surg 32:1253–1263PubMedCrossRef
22.
Zurück zum Zitat Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 237:794–800PubMedCrossRef Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 237:794–800PubMedCrossRef
23.
Zurück zum Zitat Papini E, Guglielmi R, Bianchini A et al (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRef Papini E, Guglielmi R, Bianchini A et al (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRef
24.
Zurück zum Zitat Horvath E, Maylis S, Rossi R et al (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94:1748–1751PubMedCrossRef Horvath E, Maylis S, Rossi R et al (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94:1748–1751PubMedCrossRef
25.
Zurück zum Zitat Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132PubMedCrossRef Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132PubMedCrossRef
26.
Zurück zum Zitat Brauer VF, Brauer WH, Führer D et al (2005) Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a German university study population. Thyroid 15:364–370PubMedCrossRef Brauer VF, Brauer WH, Führer D et al (2005) Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a German university study population. Thyroid 15:364–370PubMedCrossRef
27.
Zurück zum Zitat Theissen P, Schmidt M, Ivanova T et al (2009) MIBI scintigraphy in hypofunctional thyroid nodules—can it predict the dignity of a lesion? Nuklearmedizin 48:144–152PubMed Theissen P, Schmidt M, Ivanova T et al (2009) MIBI scintigraphy in hypofunctional thyroid nodules—can it predict the dignity of a lesion? Nuklearmedizin 48:144–152PubMed
28.
Zurück zum Zitat Giovanella L, Suriano S, Maffioli M et al (2010) (99 m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck 32:607–611PubMed Giovanella L, Suriano S, Maffioli M et al (2010) (99 m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck 32:607–611PubMed
29.
Zurück zum Zitat D’Souza MM, Marwaha RK, Sharma R et al (2010) Prospective evaluation of solitary thyroid nodules on 18 F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med 24:345–355PubMedCrossRef D’Souza MM, Marwaha RK, Sharma R et al (2010) Prospective evaluation of solitary thyroid nodules on 18 F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med 24:345–355PubMedCrossRef
30.
Zurück zum Zitat Ty H, Liou MJ, Lin KJ et al (2011) Prevalence and significance of thyroid uptake detected by (18)F-FDG PET. Endocrine 40:297–302CrossRef Ty H, Liou MJ, Lin KJ et al (2011) Prevalence and significance of thyroid uptake detected by (18)F-FDG PET. Endocrine 40:297–302CrossRef
31.
Zurück zum Zitat Farrag TY, Samlan RA, Lin FR et al (2006) The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 116:235–238PubMedCrossRef Farrag TY, Samlan RA, Lin FR et al (2006) The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 116:235–238PubMedCrossRef
32.
Zurück zum Zitat Randolph GW, Kamani D (2006) The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 139:357–362PubMedCrossRef Randolph GW, Kamani D (2006) The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 139:357–362PubMedCrossRef
33.
Zurück zum Zitat Scheuba C, Kaserer K, Weinhäusl A et al (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089–1095PubMedCrossRef Scheuba C, Kaserer K, Weinhäusl A et al (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089–1095PubMedCrossRef
34.
Zurück zum Zitat Karges W, Dralle H, Raue F et al (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef Karges W, Dralle H, Raue F et al (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef
35.
Zurück zum Zitat Costante G, Meringolo D, Durante C et al (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450–455PubMedCrossRef Costante G, Meringolo D, Durante C et al (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450–455PubMedCrossRef
36.
Zurück zum Zitat Elisei R, Bottici V, Luchetti F et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163–168PubMedCrossRef Elisei R, Bottici V, Luchetti F et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163–168PubMedCrossRef
37.
Zurück zum Zitat Doyle P, Duren C, Nerlich K et al (2009) Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970–2974PubMedCrossRef Doyle P, Duren C, Nerlich K et al (2009) Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970–2974PubMedCrossRef
38.
Zurück zum Zitat Colombo C, Verga U, Mian C et al (2012) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905–913PubMedCrossRef Colombo C, Verga U, Mian C et al (2012) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905–913PubMedCrossRef
39.
Zurück zum Zitat Rink T, Truong PN, Schroth HJ et al (2009) Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327–332PubMedCrossRef Rink T, Truong PN, Schroth HJ et al (2009) Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327–332PubMedCrossRef
40.
Zurück zum Zitat Scheuba C, Kaserer K, Moritz A et al (2009) Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 16:243–253PubMedCrossRef Scheuba C, Kaserer K, Moritz A et al (2009) Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 16:243–253PubMedCrossRef
41.
Zurück zum Zitat Machens A, Hoffmann F, Sekulla C et al (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291–1298PubMedCrossRef Machens A, Hoffmann F, Sekulla C et al (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291–1298PubMedCrossRef
42.
Zurück zum Zitat Milone F, Ramundo V, Chiofalo MG et al (2010) Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol 73:85–88 Milone F, Ramundo V, Chiofalo MG et al (2010) Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol 73:85–88
43.
Zurück zum Zitat Kloos R (2010) Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 95:5241–5248PubMedCrossRef Kloos R (2010) Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 95:5241–5248PubMedCrossRef
44.
Zurück zum Zitat Miyauchi A, Kudo T, Miya A et al (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:707–716PubMedCrossRef Miyauchi A, Kudo T, Miya A et al (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:707–716PubMedCrossRef
45.
Zurück zum Zitat Suh I, Vriens MR, Guerrero MA et al (2010) Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg 200:41–46PubMedCrossRef Suh I, Vriens MR, Guerrero MA et al (2010) Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg 200:41–46PubMedCrossRef
46.
Zurück zum Zitat Ci L, Zedenius J, Skoog L (2008) Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 32:1247–1252CrossRef Ci L, Zedenius J, Skoog L (2008) Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 32:1247–1252CrossRef
47.
Zurück zum Zitat Ting S, Bockisch A, Führer D, Tötsch M, Schmid KW (2012) Feinnadelbioposie (FNB) der Schilddrüse. Nuklearmedizin 35:1–8, GermanCrossRef Ting S, Bockisch A, Führer D, Tötsch M, Schmid KW (2012) Feinnadelbioposie (FNB) der Schilddrüse. Nuklearmedizin 35:1–8, GermanCrossRef
48.
Zurück zum Zitat Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159–1165PubMedCrossRef Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159–1165PubMedCrossRef
49.
Zurück zum Zitat Pang T, Ihre-Lundgren C, Gill A et al (2010) Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. Surgery 148:532–537PubMedCrossRef Pang T, Ihre-Lundgren C, Gill A et al (2010) Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. Surgery 148:532–537PubMedCrossRef
50.
Zurück zum Zitat Deandrea M, Ragazzoni F, Motta M et al (2010) Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 10:1077–1083CrossRef Deandrea M, Ragazzoni F, Motta M et al (2010) Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 10:1077–1083CrossRef
51.
Zurück zum Zitat Lew IJ, Snyder RA, Sanchez YM et al (2011) Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg 213:188–195PubMedCrossRef Lew IJ, Snyder RA, Sanchez YM et al (2011) Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg 213:188–195PubMedCrossRef
52.
Zurück zum Zitat Wang CCC, Friedman L, Kennedy GC et al (2011) A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21:243–251PubMedCrossRef Wang CCC, Friedman L, Kennedy GC et al (2011) A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21:243–251PubMedCrossRef
53.
Zurück zum Zitat Polyzos SA, Anastasilakis AD (2010) A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy. World J Surg 34:844–851PubMedCrossRef Polyzos SA, Anastasilakis AD (2010) A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy. World J Surg 34:844–851PubMedCrossRef
54.
Zurück zum Zitat Moses W, Weng J, Sansano I et al (2010) Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34:2589–2594PubMedCrossRef Moses W, Weng J, Sansano I et al (2010) Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34:2589–2594PubMedCrossRef
55.
Zurück zum Zitat Xing M (2010) Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 321:86–93PubMedCrossRef Xing M (2010) Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 321:86–93PubMedCrossRef
56.
Zurück zum Zitat Colanta A, Lin O, Tafe L et al (2011) BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Acta Cytol 55:563–569PubMedCrossRef Colanta A, Lin O, Tafe L et al (2011) BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Acta Cytol 55:563–569PubMedCrossRef
57.
Zurück zum Zitat Dralle H, Machens A (2008) Surgical approaches in thyroid cancer and lymph node metastases. Best Pract Res Clin Endocrinol Metab 22:971–987PubMedCrossRef Dralle H, Machens A (2008) Surgical approaches in thyroid cancer and lymph node metastases. Best Pract Res Clin Endocrinol Metab 22:971–987PubMedCrossRef
58.
Zurück zum Zitat Dralle H, Lorenz K, Machens A (2009) Chirurgie der Schilddrüsenkarzinome. Chirurg 80:1069–1083, GermanPubMedCrossRef Dralle H, Lorenz K, Machens A (2009) Chirurgie der Schilddrüsenkarzinome. Chirurg 80:1069–1083, GermanPubMedCrossRef
59.
Zurück zum Zitat Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121PubMedCrossRef Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121PubMedCrossRef
60.
Zurück zum Zitat Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef
61.
Zurück zum Zitat Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158PubMedCrossRef Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158PubMedCrossRef
62.
Zurück zum Zitat Wittekind C, Greene FL, Henson DE et al (2003) TNM supplement, 3rd edn. Wiley-Liss, New York, pp 25–33CrossRef Wittekind C, Greene FL, Henson DE et al (2003) TNM supplement, 3rd edn. Wiley-Liss, New York, pp 25–33CrossRef
63.
Zurück zum Zitat Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256PubMedCrossRef Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256PubMedCrossRef
64.
Zurück zum Zitat Von Lanz T, Wachsmuth W (1955) Praktische Anatomie, Hals. Springer, Berlin, pp 243–244, GermanCrossRef Von Lanz T, Wachsmuth W (1955) Praktische Anatomie, Hals. Springer, Berlin, pp 243–244, GermanCrossRef
65.
Zurück zum Zitat Földi M, Kubik S (1989) Lehrbuch der Lymphologie. Fischer, Stuttgart, pp 27–50, German Földi M, Kubik S (1989) Lehrbuch der Lymphologie. Fischer, Stuttgart, pp 27–50, German
66.
Zurück zum Zitat Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsenkarzinom. Chirurg 67:788–806, GermanPubMedCrossRef Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsenkarzinom. Chirurg 67:788–806, GermanPubMedCrossRef
67.
Zurück zum Zitat Lerch H, Schober O, Kuwert T et al (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075PubMed Lerch H, Schober O, Kuwert T et al (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075PubMed
68.
Zurück zum Zitat Schmid KW, Sheu SY, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372, GermanPubMedCrossRef Schmid KW, Sheu SY, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372, GermanPubMedCrossRef
69.
Zurück zum Zitat Carling T, Ocal IT, Udelsman R (2007) Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 31:916–923PubMedCrossRef Carling T, Ocal IT, Udelsman R (2007) Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 31:916–923PubMedCrossRef
70.
Zurück zum Zitat Scheumann GF, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568PubMedCrossRef Scheumann GF, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568PubMedCrossRef
71.
Zurück zum Zitat Kouvaraki MA, Lee JE, Shapiro SE et al (2004) Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136:1183–1191PubMedCrossRef Kouvaraki MA, Lee JE, Shapiro SE et al (2004) Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136:1183–1191PubMedCrossRef
72.
Zurück zum Zitat Evans DB (2011) Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. Surgery 150:1015–1022PubMedCrossRef Evans DB (2011) Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. Surgery 150:1015–1022PubMedCrossRef
73.
Zurück zum Zitat Dralle H, Machens A (2012) Primary surgery for differentiated thyroid cancer in the new millennium. J Endocrinol Invest 35(6 Suppl):10–15PubMed Dralle H, Machens A (2012) Primary surgery for differentiated thyroid cancer in the new millennium. J Endocrinol Invest 35(6 Suppl):10–15PubMed
74.
Zurück zum Zitat Passler C, Scheuba C, Asari R et al (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92:184–189PubMedCrossRef Passler C, Scheuba C, Asari R et al (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92:184–189PubMedCrossRef
75.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–384PubMedCrossRef Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–384PubMedCrossRef
76.
Zurück zum Zitat Rahbar K, Hutenlaub V, Fischer RJ et al (2008) Risk-profile and outcome of small papillary and follicular thyroid carcinomas (≤1 cm). Nuklearmedizin 47:1881–1893 Rahbar K, Hutenlaub V, Fischer RJ et al (2008) Risk-profile and outcome of small papillary and follicular thyroid carcinomas (≤1 cm). Nuklearmedizin 47:1881–1893
77.
Zurück zum Zitat Vaisman F, Shaha A, Fish S et al (2011) Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol 75:112–119CrossRef Vaisman F, Shaha A, Fish S et al (2011) Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol 75:112–119CrossRef
78.
Zurück zum Zitat Reiners C, Hänscheid H, Luster M et al (2011) Radioiodine for remnant ablation and therapy of metastatic disease. Nat Rev Endocrinol 7:589–595PubMedCrossRef Reiners C, Hänscheid H, Luster M et al (2011) Radioiodine for remnant ablation and therapy of metastatic disease. Nat Rev Endocrinol 7:589–595PubMedCrossRef
79.
Zurück zum Zitat Dralle H, Lorenz K, Machens A et al (2009) Postoperativer Zufallsbefund Schildrüsenkarzinom: chirurgisches Konzept. Dtsch Med Wochenschr 134:2517–2520, GermanPubMedCrossRef Dralle H, Lorenz K, Machens A et al (2009) Postoperativer Zufallsbefund Schildrüsenkarzinom: chirurgisches Konzept. Dtsch Med Wochenschr 134:2517–2520, GermanPubMedCrossRef
80.
Zurück zum Zitat Lee KJ, Cho YJ, Kim SJ et al (2011) Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg 35:318–323PubMedCrossRef Lee KJ, Cho YJ, Kim SJ et al (2011) Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg 35:318–323PubMedCrossRef
81.
Zurück zum Zitat Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMed Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMed
82.
Zurück zum Zitat Roti E, Uberti EC, Bondanelli M et al (2008) Thyroid papillary microcarcinoma: a descriptive and metaanalysis study. Eur J Endocrinol 159:659–673PubMedCrossRef Roti E, Uberti EC, Bondanelli M et al (2008) Thyroid papillary microcarcinoma: a descriptive and metaanalysis study. Eur J Endocrinol 159:659–673PubMedCrossRef
83.
Zurück zum Zitat Perrino M, Vannucchi G, Vicentini L et al (2009) Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancer ≤2 cm. Endocrinol Relat Cancer 16:201–210CrossRef Perrino M, Vannucchi G, Vicentini L et al (2009) Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancer ≤2 cm. Endocrinol Relat Cancer 16:201–210CrossRef
84.
Zurück zum Zitat Pitt SC, Sippel RS, Chen H (2009) Contralateral papillary thyroid cancer: does size matter? Am J Surg 197:342–347PubMedCrossRef Pitt SC, Sippel RS, Chen H (2009) Contralateral papillary thyroid cancer: does size matter? Am J Surg 197:342–347PubMedCrossRef
85.
Zurück zum Zitat Bonnet S, Leboulleux S, Baudin E et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167PubMedCrossRef Bonnet S, Leboulleux S, Baudin E et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167PubMedCrossRef
86.
Zurück zum Zitat Wang W, Wang H, Teng X et al (2010) Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol 41:1299–1309PubMedCrossRef Wang W, Wang H, Teng X et al (2010) Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol 41:1299–1309PubMedCrossRef
87.
Zurück zum Zitat Bernet V (2010) Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 8:3586–3592CrossRef Bernet V (2010) Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 8:3586–3592CrossRef
88.
Zurück zum Zitat Neuhold N, Schultheis A, Hermann M et al (2011) Incidental papillary microcarcinoma of the thyroid—further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow up. Ann Surg Oncol 12:3430–3436CrossRef Neuhold N, Schultheis A, Hermann M et al (2011) Incidental papillary microcarcinoma of the thyroid—further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow up. Ann Surg Oncol 12:3430–3436CrossRef
89.
Zurück zum Zitat Naing S, Collins BJ, Schneider AB (2009) Clinical behaviour of radiation-induced thyroid cancer: factors related to recurrence. Thyroid 19:479–485PubMedCrossRef Naing S, Collins BJ, Schneider AB (2009) Clinical behaviour of radiation-induced thyroid cancer: factors related to recurrence. Thyroid 19:479–485PubMedCrossRef
90.
Zurück zum Zitat Yu XM, Wan Y, Sippel RS et al (2011) Should all papillary thyroid microcarcinoma be aggressively treated? Ann Surg 254:653–660PubMedCrossRef Yu XM, Wan Y, Sippel RS et al (2011) Should all papillary thyroid microcarcinoma be aggressively treated? Ann Surg 254:653–660PubMedCrossRef
91.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: Massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786PubMedCrossRef Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: Massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786PubMedCrossRef
92.
Zurück zum Zitat Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716PubMedCrossRef Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716PubMedCrossRef
93.
Zurück zum Zitat Rivera M, Ricarte-Filho J, Tuttle RM et al (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 20:1085–1093PubMedCrossRef Rivera M, Ricarte-Filho J, Tuttle RM et al (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 20:1085–1093PubMedCrossRef
94.
Zurück zum Zitat Fukushima M, Ito Y, Hirokawa M et al (2010) Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size. World J Surg 34:3007–3014PubMedCrossRef Fukushima M, Ito Y, Hirokawa M et al (2010) Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size. World J Surg 34:3007–3014PubMedCrossRef
95.
Zurück zum Zitat Moon HJ, Kim EK, Chung WY et al (2011) Minimal extrathroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923PubMedCrossRef Moon HJ, Kim EK, Chung WY et al (2011) Minimal extrathroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923PubMedCrossRef
96.
Zurück zum Zitat So YK, Son YI, Hong SD et al (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526–531PubMedCrossRef So YK, Son YI, Hong SD et al (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526–531PubMedCrossRef
97.
Zurück zum Zitat Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and metaanalysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119:1135–1139PubMedCrossRef Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and metaanalysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119:1135–1139PubMedCrossRef
98.
Zurück zum Zitat Hughes DT, White ML, Miller BS et al (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1107PubMedCrossRef Hughes DT, White ML, Miller BS et al (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1107PubMedCrossRef
99.
Zurück zum Zitat Moo TA, McGill J, Allendorf J et al (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34:1187–1191PubMedCrossRef Moo TA, McGill J, Allendorf J et al (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34:1187–1191PubMedCrossRef
100.
Zurück zum Zitat Giordano D, Valcavi R, Thompson GB et al (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22:911–917PubMedCrossRef Giordano D, Valcavi R, Thompson GB et al (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22:911–917PubMedCrossRef
101.
Zurück zum Zitat Kouvaraki MA, Shapiro SE, Fornage BD et al (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946–955PubMedCrossRef Kouvaraki MA, Shapiro SE, Fornage BD et al (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946–955PubMedCrossRef
102.
Zurück zum Zitat Stulak JM, Grant CS, Farley DR et al (2006) Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489–496PubMedCrossRef Stulak JM, Grant CS, Farley DR et al (2006) Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489–496PubMedCrossRef
103.
Zurück zum Zitat Machens A, Hauptmann S, Dralle H (2009) Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 145:176–181PubMedCrossRef Machens A, Hauptmann S, Dralle H (2009) Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 145:176–181PubMedCrossRef
104.
Zurück zum Zitat Lee YS, Lim YS, Lee JC et al (2010) Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 34:2558–2563PubMedCrossRef Lee YS, Lim YS, Lee JC et al (2010) Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 34:2558–2563PubMedCrossRef
105.
Zurück zum Zitat Machens A, Dralle H (2012) Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97:4375–4382PubMedCrossRef Machens A, Dralle H (2012) Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97:4375–4382PubMedCrossRef
106.
Zurück zum Zitat Moo TA, Umunna B, Kato M et al (2009) Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 250:403–408PubMed Moo TA, Umunna B, Kato M et al (2009) Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 250:403–408PubMed
107.
Zurück zum Zitat Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–705PubMedCrossRef Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–705PubMedCrossRef
108.
Zurück zum Zitat Pereira JA, Jimeno J, Miquel J et al (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095–1101PubMedCrossRef Pereira JA, Jimeno J, Miquel J et al (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095–1101PubMedCrossRef
109.
Zurück zum Zitat White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904PubMedCrossRef White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904PubMedCrossRef
110.
Zurück zum Zitat Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689PubMedCrossRef Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689PubMedCrossRef
111.
Zurück zum Zitat Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148:398–403PubMedCrossRef Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148:398–403PubMedCrossRef
112.
Zurück zum Zitat Zetoune T, Keutgen X, Buitrago D et al (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17:3287–3293PubMedCrossRef Zetoune T, Keutgen X, Buitrago D et al (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17:3287–3293PubMedCrossRef
113.
Zurück zum Zitat Popadich A, Levin O, Lee JC et al (2011) A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048–1057PubMedCrossRef Popadich A, Levin O, Lee JC et al (2011) A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048–1057PubMedCrossRef
114.
Zurück zum Zitat Cooper DS, Tufano RP (2012) Prophylactic central neck dissection in differentiated thyroid cancer: a procedure in search of an indication. Thyroid 4:341–343CrossRef Cooper DS, Tufano RP (2012) Prophylactic central neck dissection in differentiated thyroid cancer: a procedure in search of an indication. Thyroid 4:341–343CrossRef
115.
Zurück zum Zitat Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1008PubMedCrossRef Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1008PubMedCrossRef
116.
117.
Zurück zum Zitat O’Neill CJ, Bullock M, Chou A et al (2010) BRAF V600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 148:1139–1146PubMedCrossRef O’Neill CJ, Bullock M, Chou A et al (2010) BRAF V600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 148:1139–1146PubMedCrossRef
118.
Zurück zum Zitat Basolo F, Torregrossa L, Giannini R et al (2010) Correlation between BRAFV600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 95:4197–4205PubMedCrossRef Basolo F, Torregrossa L, Giannini R et al (2010) Correlation between BRAFV600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 95:4197–4205PubMedCrossRef
119.
Zurück zum Zitat Kim SJ, Lee KE, Myong JP et al (2012) BRAFV600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg 36:310–317PubMedCrossRef Kim SJ, Lee KE, Myong JP et al (2012) BRAFV600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg 36:310–317PubMedCrossRef
120.
Zurück zum Zitat Ricarte-Filho J, Ganly I, Rivera M et al (2012) Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 22:575–584PubMedCrossRef Ricarte-Filho J, Ganly I, Rivera M et al (2012) Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 22:575–584PubMedCrossRef
121.
Zurück zum Zitat Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28PubMedCrossRef Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28PubMedCrossRef
122.
Zurück zum Zitat Chung YS, Kim JY, Bae JS et al (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid 19:241–246PubMedCrossRef Chung YS, Kim JY, Bae JS et al (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid 19:241–246PubMedCrossRef
123.
Zurück zum Zitat Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139:43–45PubMedCrossRef Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139:43–45PubMedCrossRef
124.
Zurück zum Zitat Park JH, Lee YS, Kim BW et al (2012) Skip lateral neck node metastases in papillary thyroid carcinoma. World J Surg 36:743–747PubMedCrossRef Park JH, Lee YS, Kim BW et al (2012) Skip lateral neck node metastases in papillary thyroid carcinoma. World J Surg 36:743–747PubMedCrossRef
125.
Zurück zum Zitat Zhang L, Wei WJ, Ji OH et al (2012) Risk factors for neck metastasis in papillary thyroid carcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97:1250–1257PubMedCrossRef Zhang L, Wei WJ, Ji OH et al (2012) Risk factors for neck metastasis in papillary thyroid carcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97:1250–1257PubMedCrossRef
126.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T et al (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920PubMedCrossRef Ito Y, Tomoda C, Uruno T et al (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920PubMedCrossRef
127.
Zurück zum Zitat Ito Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31:905–915PubMedCrossRef Ito Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31:905–915PubMedCrossRef
128.
Zurück zum Zitat Caron NR, Tan YY, Ogilvie JB et al (2006) Selective modified radical neck dissection for papillary thyroid cancer—is level I, II and V dissection always necessary? World J Surg 30:833–840PubMedCrossRef Caron NR, Tan YY, Ogilvie JB et al (2006) Selective modified radical neck dissection for papillary thyroid cancer—is level I, II and V dissection always necessary? World J Surg 30:833–840PubMedCrossRef
129.
Zurück zum Zitat Lim YC, Choi EC, Yoon YH et al (2010) Occult lymph node metastases in neck level V in papillary thyroid carcinoma. Surgery 147:241–245PubMedCrossRef Lim YC, Choi EC, Yoon YH et al (2010) Occult lymph node metastases in neck level V in papillary thyroid carcinoma. Surgery 147:241–245PubMedCrossRef
130.
Zurück zum Zitat Remmler D, Byers R, Scheetz J et al (1986) A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg 8:280–286PubMedCrossRef Remmler D, Byers R, Scheetz J et al (1986) A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg 8:280–286PubMedCrossRef
131.
Zurück zum Zitat van Wilgen CP, Dijkstra PU, van der Laan BF et al (2004) Shoulder complaints after nerve sparing neck dissections. Int J Oral Maxillofac Surg 33:252–527 van Wilgen CP, Dijkstra PU, van der Laan BF et al (2004) Shoulder complaints after nerve sparing neck dissections. Int J Oral Maxillofac Surg 33:252–527
132.
Zurück zum Zitat Kupferman ME, Patterson M, Mandel SJ et al (2004) Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 114:403–406PubMedCrossRef Kupferman ME, Patterson M, Mandel SJ et al (2004) Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 114:403–406PubMedCrossRef
133.
Zurück zum Zitat Roh JL, Kim DH, Park CI (2008) Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol 15:424–429PubMedCrossRef Roh JL, Kim DH, Park CI (2008) Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol 15:424–429PubMedCrossRef
134.
Zurück zum Zitat Lorenz K, Abuazab M, Sekulla C et al (2010) Management of lymph fistulas in thyroid surgery. Langenbeck’s Arch Surg 395:911–917CrossRef Lorenz K, Abuazab M, Sekulla C et al (2010) Management of lymph fistulas in thyroid surgery. Langenbeck’s Arch Surg 395:911–917CrossRef
135.
Zurück zum Zitat McGarvey AC, Chiarelli PE, Osmotherly PG et al (2011) Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck 33:274–280PubMedCrossRef McGarvey AC, Chiarelli PE, Osmotherly PG et al (2011) Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck 33:274–280PubMedCrossRef
136.
Zurück zum Zitat Ito Y, Higashiyama T, Takamura Y et al (2007) Risk factors for recurrence to the lymph node in papillary throid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085–2091PubMedCrossRef Ito Y, Higashiyama T, Takamura Y et al (2007) Risk factors for recurrence to the lymph node in papillary throid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085–2091PubMedCrossRef
137.
Zurück zum Zitat Machens A, Dralle H (2009) Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171–176PubMedCrossRef Machens A, Dralle H (2009) Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171–176PubMedCrossRef
138.
Zurück zum Zitat Dralle H, Scheumann GFW, Hundeshagen H et al (1992) Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom. Langenbecks Arch Chir 377:34–44, GermanPubMedCrossRef Dralle H, Scheumann GFW, Hundeshagen H et al (1992) Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom. Langenbecks Arch Chir 377:34–44, GermanPubMedCrossRef
139.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T et al (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36:12–18PubMedCrossRef Ito Y, Tomoda C, Uruno T et al (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36:12–18PubMedCrossRef
140.
Zurück zum Zitat Nixon IJ, Ganly I, Patel S et al (2011) The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery 150:1242–1249PubMedCrossRef Nixon IJ, Ganly I, Patel S et al (2011) The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery 150:1242–1249PubMedCrossRef
141.
Zurück zum Zitat Dralle H, Scheumann GFW, Meyer HU et al (1992) Zervikale Eingriffe an der Luft- und Speiseröhre beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 63:282–290, GermanPubMed Dralle H, Scheumann GFW, Meyer HU et al (1992) Zervikale Eingriffe an der Luft- und Speiseröhre beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 63:282–290, GermanPubMed
142.
Zurück zum Zitat Dralle H, Brauckhoff M, Machens A et al (2005) Surgical management of advanced thyroid cancer invading the aerodigestive tract. In: Clark OH, Duh QY, Kebebew E (eds) Textbook on endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 318–333CrossRef Dralle H, Brauckhoff M, Machens A et al (2005) Surgical management of advanced thyroid cancer invading the aerodigestive tract. In: Clark OH, Duh QY, Kebebew E (eds) Textbook on endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 318–333CrossRef
143.
Zurück zum Zitat Brauckhoff M, Meinicke A, Bilkenroth U et al (2006) Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. Surgery 140:953–955PubMedCrossRef Brauckhoff M, Meinicke A, Bilkenroth U et al (2006) Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. Surgery 140:953–955PubMedCrossRef
144.
Zurück zum Zitat Brauckhoff M, Dralle H (2009) Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 80:88–98PubMedCrossRef Brauckhoff M, Dralle H (2009) Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 80:88–98PubMedCrossRef
145.
Zurück zum Zitat Musholt TJ, Musholt PB, Behrend M et al (1999) Invasive differentiated thyroid carcinoma: tracheal resection and reconstruction procedures in the hands of the endocrine surgeon. Surgery 126:1078–1087PubMedCrossRef Musholt TJ, Musholt PB, Behrend M et al (1999) Invasive differentiated thyroid carcinoma: tracheal resection and reconstruction procedures in the hands of the endocrine surgeon. Surgery 126:1078–1087PubMedCrossRef
146.
Zurück zum Zitat Brauckhoff M, Machens A, Nguyen Thanh P et al (2010) Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence and cancer-specific survival. Surgery 148:1257–1266PubMedCrossRef Brauckhoff M, Machens A, Nguyen Thanh P et al (2010) Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence and cancer-specific survival. Surgery 148:1257–1266PubMedCrossRef
147.
Zurück zum Zitat Randolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12:989–996PubMedCrossRef Randolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12:989–996PubMedCrossRef
148.
Zurück zum Zitat Bal CS, Kumar A, Pant GS (2003) Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Nucl Med Commun 24:203–208PubMedCrossRef Bal CS, Kumar A, Pant GS (2003) Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer. Nucl Med Commun 24:203–208PubMedCrossRef
149.
Zurück zum Zitat Barbesino G, Goldfarb M, Parangi S et al (2012) Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow up. Thyroid 22:369–376PubMedCrossRef Barbesino G, Goldfarb M, Parangi S et al (2012) Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow up. Thyroid 22:369–376PubMedCrossRef
150.
Zurück zum Zitat Glockzin G, Hornung M, Kienle K et al (2012) Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg 36:1168–1173PubMedCrossRef Glockzin G, Hornung M, Kienle K et al (2012) Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg 36:1168–1173PubMedCrossRef
151.
Zurück zum Zitat Scheumann GFW, Seeliger H, Musholt TJ et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed Scheumann GFW, Seeliger H, Musholt TJ et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed
152.
Zurück zum Zitat Walgenbach S, Junginger T (2002) Beeinflußt der Zeitpunkt der Restthyreoidektomie die Prognose differenzierter Schilddrüsenkarzinome? Zentralbl Chir 127:435–438, GermanPubMedCrossRef Walgenbach S, Junginger T (2002) Beeinflußt der Zeitpunkt der Restthyreoidektomie die Prognose differenzierter Schilddrüsenkarzinome? Zentralbl Chir 127:435–438, GermanPubMedCrossRef
153.
Zurück zum Zitat Schmid KW, Ting S, Sheu SY (2010) Familiäre Karzinome der Schilddrüse. Pathologe 31:485–488, GermanPubMedCrossRef Schmid KW, Ting S, Sheu SY (2010) Familiäre Karzinome der Schilddrüse. Pathologe 31:485–488, GermanPubMedCrossRef
154.
Zurück zum Zitat Charkes ND (2006) On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181–186PubMedCrossRef Charkes ND (2006) On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181–186PubMedCrossRef
155.
Zurück zum Zitat Musholt TJ, Musholt PB, Petrich T et al (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features and surgical treatment. World J Surg 24:1409–1417PubMedCrossRef Musholt TJ, Musholt PB, Petrich T et al (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features and surgical treatment. World J Surg 24:1409–1417PubMedCrossRef
156.
Zurück zum Zitat Reiners C, Biko J, Demdchik EP et al (2001) Thyroid cancer in Chernobyl children. In: Biersack HJ, Grünwald F (eds) Thyroid cancer. Springer, Berlin, pp 225–235CrossRef Reiners C, Biko J, Demdchik EP et al (2001) Thyroid cancer in Chernobyl children. In: Biersack HJ, Grünwald F (eds) Thyroid cancer. Springer, Berlin, pp 225–235CrossRef
157.
Zurück zum Zitat Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259–277PubMedCrossRef Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259–277PubMedCrossRef
158.
Zurück zum Zitat Zimmermann D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: Long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166 Zimmermann D, Hay ID, Gough IR et al (1988) Papillary thyroid carcinoma in children and adults: Long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166
159.
Zurück zum Zitat Vassilopoulou-Sellin R, Goepfert H, Raney B et al (1998) Differentiated thyroid cancer in children and adolescent: Clinical outcome and mortality after long-term follow-up. Head Neck 20:549–555PubMedCrossRef Vassilopoulou-Sellin R, Goepfert H, Raney B et al (1998) Differentiated thyroid cancer in children and adolescent: Clinical outcome and mortality after long-term follow-up. Head Neck 20:549–555PubMedCrossRef
160.
Zurück zum Zitat Leboulleux S, Baudin E, Hartl DW et al (2005) Follicular cell-derived thyroid cancer in children. Horm Res 63:145–151PubMedCrossRef Leboulleux S, Baudin E, Hartl DW et al (2005) Follicular cell-derived thyroid cancer in children. Horm Res 63:145–151PubMedCrossRef
161.
Zurück zum Zitat Machens A, Lorenz K, Nguyen Thanh P et al (2010) Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. J Pediatr 157:648–652PubMedCrossRef Machens A, Lorenz K, Nguyen Thanh P et al (2010) Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. J Pediatr 157:648–652PubMedCrossRef
162.
Zurück zum Zitat Farahati J, Reiners C, Demidchik EP (1999) Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid? J Nucl Med 40:2125PubMed Farahati J, Reiners C, Demidchik EP (1999) Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid? J Nucl Med 40:2125PubMed
163.
Zurück zum Zitat Luna-Oritz K, Hurtado-Lopez LM, Valderrama-Landeata JL et al (2004) Thyroglossal duct with papillary carcinoma: what must be done? Thyroid 14:363–366CrossRef Luna-Oritz K, Hurtado-Lopez LM, Valderrama-Landeata JL et al (2004) Thyroglossal duct with papillary carcinoma: what must be done? Thyroid 14:363–366CrossRef
164.
Zurück zum Zitat Peretz A, Leiberman E, Kapelushnik J et al (2004) Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 14:777–785PubMed Peretz A, Leiberman E, Kapelushnik J et al (2004) Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 14:777–785PubMed
165.
Zurück zum Zitat Ryder M, Nikiforov YE, Fagin JA (2007) Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma. Thyroid 17:179–180PubMedCrossRef Ryder M, Nikiforov YE, Fagin JA (2007) Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma. Thyroid 17:179–180PubMedCrossRef
166.
Zurück zum Zitat Bernier MO, Leenhardt L, Hoang C et al (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573PubMedCrossRef Bernier MO, Leenhardt L, Hoang C et al (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573PubMedCrossRef
167.
Zurück zum Zitat Zettinig G, Fueger BJ, Passler C (2002) Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma—surgery or conventional therapy? Clin Endocrinol 56:377–383CrossRef Zettinig G, Fueger BJ, Passler C (2002) Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma—surgery or conventional therapy? Clin Endocrinol 56:377–383CrossRef
168.
Zurück zum Zitat Chiu AC, Delpassand ES, Sherman S (1997) Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 82:3637–3642PubMedCrossRef Chiu AC, Delpassand ES, Sherman S (1997) Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 82:3637–3642PubMedCrossRef
169.
Zurück zum Zitat McWilliams RR, Giannini C, Hay ID et al (2003) Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 98:356–362PubMedCrossRef McWilliams RR, Giannini C, Hay ID et al (2003) Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 98:356–362PubMedCrossRef
170.
Zurück zum Zitat Hundahl SA, Cady B, Cunningham MP et al (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202–217PubMedCrossRef Hundahl SA, Cady B, Cunningham MP et al (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202–217PubMedCrossRef
171.
Zurück zum Zitat Clerici T, Kolb W, Beutner U et al (2010) German Association of Endocrine Surgeons. Diagnosis and treatment of small follicular thyroid carcinomas. Br J Surg 97:839–844PubMedCrossRef Clerici T, Kolb W, Beutner U et al (2010) German Association of Endocrine Surgeons. Diagnosis and treatment of small follicular thyroid carcinomas. Br J Surg 97:839–844PubMedCrossRef
172.
Zurück zum Zitat Asari R, Koperek O, Scheuba C et al (2009) Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 249:1023–1031PubMedCrossRef Asari R, Koperek O, Scheuba C et al (2009) Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 249:1023–1031PubMedCrossRef
173.
Zurück zum Zitat Rosai J (2005) Handling of thyroid follicular patterned lesions. Endocr Pathol 6:279–284CrossRef Rosai J (2005) Handling of thyroid follicular patterned lesions. Endocr Pathol 6:279–284CrossRef
174.
Zurück zum Zitat LiVolsi VA, Balch ZW (2009) The many faces of follicular variant of papillary thyroid carcinoma. Pathol Case Rev 14:214–218CrossRef LiVolsi VA, Balch ZW (2009) The many faces of follicular variant of papillary thyroid carcinoma. Pathol Case Rev 14:214–218CrossRef
175.
Zurück zum Zitat Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393PubMedCrossRef Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393PubMedCrossRef
176.
Zurück zum Zitat Lang W, Georgii A, Stauch G et al (1980) The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol 385:125–241PubMedCrossRef Lang W, Georgii A, Stauch G et al (1980) The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol 385:125–241PubMedCrossRef
177.
Zurück zum Zitat Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552PubMedCrossRef Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552PubMedCrossRef
178.
Zurück zum Zitat Delbridge L, Barraclough B, Parkin R et al (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845PubMed Delbridge L, Barraclough B, Parkin R et al (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845PubMed
179.
Zurück zum Zitat Brennan MD, Bergstralh EJ, van Heerden JA et al (1991) Follicular thyroid cancer treated at the Mayo clinic 1946 through 1970: initial manifestations, pathologic, findings, therapy, and outcome. Mayo Clin Proc 66:11–22PubMedCrossRef Brennan MD, Bergstralh EJ, van Heerden JA et al (1991) Follicular thyroid cancer treated at the Mayo clinic 1946 through 1970: initial manifestations, pathologic, findings, therapy, and outcome. Mayo Clin Proc 66:11–22PubMedCrossRef
180.
Zurück zum Zitat Van Heerden JA, Hay ID, Goellner JR et al (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1138PubMed Van Heerden JA, Hay ID, Goellner JR et al (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1138PubMed
181.
Zurück zum Zitat O’ Neill CJ, Vaughan L, Learoyd DL et al (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37:181–185CrossRef O’ Neill CJ, Vaughan L, Learoyd DL et al (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37:181–185CrossRef
182.
Zurück zum Zitat Chen H, Nicol TL, Udelsman R (1995) Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222:101–106PubMedCrossRef Chen H, Nicol TL, Udelsman R (1995) Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222:101–106PubMedCrossRef
183.
Zurück zum Zitat Udelsman R, Westra WH, Donovan PI et al (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233:716–722PubMedCrossRef Udelsman R, Westra WH, Donovan PI et al (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233:716–722PubMedCrossRef
184.
Zurück zum Zitat Miller MC, Rubin CJ, Cunnane M et al (2007) Intraoperative pathologic examination: cost effectiveness and clinical value in patients with cytologic diagnosis of cellular follicular thyroid lesion. Thyroid 17:557–565PubMedCrossRef Miller MC, Rubin CJ, Cunnane M et al (2007) Intraoperative pathologic examination: cost effectiveness and clinical value in patients with cytologic diagnosis of cellular follicular thyroid lesion. Thyroid 17:557–565PubMedCrossRef
185.
Zurück zum Zitat Basolo F, Ugolini C, Proietti A et al (2007) Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules. Eur J Surg Oncol 33:769–775PubMedCrossRef Basolo F, Ugolini C, Proietti A et al (2007) Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules. Eur J Surg Oncol 33:769–775PubMedCrossRef
186.
Zurück zum Zitat Lin HS, Komisar A, Opher E et al (2000) Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope 110:1431–1436PubMedCrossRef Lin HS, Komisar A, Opher E et al (2000) Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope 110:1431–1436PubMedCrossRef
187.
Zurück zum Zitat Baloch Z, LiVolsi VA, Jain P et al (2003) Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol 29:203–206PubMedCrossRef Baloch Z, LiVolsi VA, Jain P et al (2003) Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol 29:203–206PubMedCrossRef
188.
Zurück zum Zitat Dralle H (2007) Inzidentalome der Schilddrüse. Überdiagnostik und-therapie gesunder Schilddrüsenkranker? Chirurg 78:677–686, GermanPubMedCrossRef Dralle H (2007) Inzidentalome der Schilddrüse. Überdiagnostik und-therapie gesunder Schilddrüsenkranker? Chirurg 78:677–686, GermanPubMedCrossRef
189.
Zurück zum Zitat Huang CC, Hsueh C, Liu FH et al (2001) Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol 20:1–6CrossRef Huang CC, Hsueh C, Liu FH et al (2001) Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol 20:1–6CrossRef
190.
Zurück zum Zitat Sugino K, Ito K, Nagahama M et al (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21:751–757PubMedCrossRef Sugino K, Ito K, Nagahama M et al (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21:751–757PubMedCrossRef
191.
Zurück zum Zitat Machens A, Holzhausen HJ, Lautenschlager C et al (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98:712–719PubMedCrossRef Machens A, Holzhausen HJ, Lautenschlager C et al (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98:712–719PubMedCrossRef
192.
Zurück zum Zitat Lopez-Penabad L, Chiu AC, Hoff AO et al (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186–1194PubMedCrossRef Lopez-Penabad L, Chiu AC, Hoff AO et al (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186–1194PubMedCrossRef
193.
Zurück zum Zitat Carcangiu ML (2003) Hürthle cell carcinoma: clinic-pathological and biological aspects. Tumori 89:529–532PubMed Carcangiu ML (2003) Hürthle cell carcinoma: clinic-pathological and biological aspects. Tumori 89:529–532PubMed
194.
Zurück zum Zitat Kushchayeva Y, Duh QY, Kebebew E et al (2004) Prognostic indications for Hürthle cell cancer. World J Surg 28:1266–1270PubMedCrossRef Kushchayeva Y, Duh QY, Kebebew E et al (2004) Prognostic indications for Hürthle cell cancer. World J Surg 28:1266–1270PubMedCrossRef
195.
Zurück zum Zitat Carling T, Udelsman R (2005) Follicular neoplasms of the thyroid: what to recommend. Thyroid 15:583–587PubMedCrossRef Carling T, Udelsman R (2005) Follicular neoplasms of the thyroid: what to recommend. Thyroid 15:583–587PubMedCrossRef
196.
Zurück zum Zitat Besic N, Hocevar M, Zgajnar J et al (2006) Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma. Thyroid 16:67–72PubMedCrossRef Besic N, Hocevar M, Zgajnar J et al (2006) Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma. Thyroid 16:67–72PubMedCrossRef
197.
Zurück zum Zitat Montone KT, Baloch ZW, LiVolsi VA (2008) The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 132:1241–1250PubMed Montone KT, Baloch ZW, LiVolsi VA (2008) The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 132:1241–1250PubMed
198.
Zurück zum Zitat Guerrero MA, Suh I, Vriens MR et al (2010) Age and tumor size predicts lymph node involvement in Hürthle cell carcinoma. J Cancer 1:23–26PubMedCrossRef Guerrero MA, Suh I, Vriens MR et al (2010) Age and tumor size predicts lymph node involvement in Hürthle cell carcinoma. J Cancer 1:23–26PubMedCrossRef
199.
Zurück zum Zitat Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (insular”) thyroid carcinoma. A reinterpretation of Langhans “wuchernde Struma”. Am J Surg Pathol 8:655–668PubMedCrossRef Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (insular”) thyroid carcinoma. A reinterpretation of Langhans “wuchernde Struma”. Am J Surg Pathol 8:655–668PubMedCrossRef
200.
Zurück zum Zitat Sanders EM Jr, LiVolsi VA, Brierley J et al (2007) An evidence-based review of poorly differentiated thyroid carcinoma. World J Surg 31:934–945PubMedCrossRef Sanders EM Jr, LiVolsi VA, Brierley J et al (2007) An evidence-based review of poorly differentiated thyroid carcinoma. World J Surg 31:934–945PubMedCrossRef
201.
Zurück zum Zitat Volante M, Landolfi S, Chiusa L et al (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns. Cancer 100:950–957PubMedCrossRef Volante M, Landolfi S, Chiusa L et al (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns. Cancer 100:950–957PubMedCrossRef
202.
Zurück zum Zitat Hiltzik D, Carlson DL, Tuttle RM et al (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. Cancer 106:1286–1295PubMedCrossRef Hiltzik D, Carlson DL, Tuttle RM et al (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. Cancer 106:1286–1295PubMedCrossRef
203.
Zurück zum Zitat Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264PubMedCrossRef Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264PubMedCrossRef
204.
Zurück zum Zitat Volante M, Papotti M (2010) Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol 21:1–6PubMedCrossRef Volante M, Papotti M (2010) Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol 21:1–6PubMedCrossRef
205.
Zurück zum Zitat Lam KY, Lo CY, Chan KW et al (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338PubMedCrossRef Lam KY, Lo CY, Chan KW et al (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338PubMedCrossRef
206.
Zurück zum Zitat Dettmer M, Schmitt A, Steinert H et al (2011) Poorly differentiated thyroid carcinomas: How much poorly differentiated is needed? Am J Surg Pathol 35:1866–1872PubMedCrossRef Dettmer M, Schmitt A, Steinert H et al (2011) Poorly differentiated thyroid carcinomas: How much poorly differentiated is needed? Am J Surg Pathol 35:1866–1872PubMedCrossRef
207.
Zurück zum Zitat Machens A, Hinze R, Lautenschläger C et al (2001) Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg 136:941–944PubMedCrossRef Machens A, Hinze R, Lautenschläger C et al (2001) Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg 136:941–944PubMedCrossRef
208.
Zurück zum Zitat Chao T-C, Lin J-D, Chen MF (2004) Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg 28:393–396PubMedCrossRef Chao T-C, Lin J-D, Chen MF (2004) Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg 28:393–396PubMedCrossRef
209.
Zurück zum Zitat Patel KN, Shaha AR (2006) Poorly differentiated and anaplastic thyroid cancer. Cancer Control 13:119–128PubMed Patel KN, Shaha AR (2006) Poorly differentiated and anaplastic thyroid cancer. Cancer Control 13:119–128PubMed
210.
Zurück zum Zitat Lai HW, Lee CH, Chen JY et al (2006) Insular thyroid carcinoma: collective analysis of clinicohistologic prognostic factors und treatment effect with radioiodine or radiation therapy. J Am Coll Surg 203:715–722PubMedCrossRef Lai HW, Lee CH, Chen JY et al (2006) Insular thyroid carcinoma: collective analysis of clinicohistologic prognostic factors und treatment effect with radioiodine or radiation therapy. J Am Coll Surg 203:715–722PubMedCrossRef
211.
Zurück zum Zitat Jung TS, Kim TY, Kim KW et al (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265–274PubMedCrossRef Jung TS, Kim TY, Kim KW et al (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265–274PubMedCrossRef
212.
Zurück zum Zitat Frilling A, Tecklenborg K, Goerges R et al (2001) Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234:804–811PubMedCrossRef Frilling A, Tecklenborg K, Goerges R et al (2001) Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234:804–811PubMedCrossRef
213.
Zurück zum Zitat Lin JD, Chao TC, Hsueh C (2007) Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin Endocrinol 66:224–228CrossRef Lin JD, Chao TC, Hsueh C (2007) Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin Endocrinol 66:224–228CrossRef
214.
Zurück zum Zitat Freudenberg LS, Bockisch A, Jentzen W (2005) 124I position emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer. In: Biersack HJ, Grünwald F (eds) Thyroid cancer, 2nd edn. Springer, Berlin, pp 127–138CrossRef Freudenberg LS, Bockisch A, Jentzen W (2005) 124I position emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer. In: Biersack HJ, Grünwald F (eds) Thyroid cancer, 2nd edn. Springer, Berlin, pp 127–138CrossRef
215.
Zurück zum Zitat Chambers AJ, Pasieka JL (2009) Poorly differentiated and undifferentiated thyroid cancer. In: Hubbard JGH, Inabnet WB, Loh CY (eds) Endocrine surgery. Springer, London, pp 121–136CrossRef Chambers AJ, Pasieka JL (2009) Poorly differentiated and undifferentiated thyroid cancer. In: Hubbard JGH, Inabnet WB, Loh CY (eds) Endocrine surgery. Springer, London, pp 121–136CrossRef
216.
Zurück zum Zitat Freudenberg LS, Antoch G, Frilling A et al (2008) Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: the role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950–957PubMedCrossRef Freudenberg LS, Antoch G, Frilling A et al (2008) Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: the role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950–957PubMedCrossRef
217.
Zurück zum Zitat Lam KY, Lo CY, Chan KW et al (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338PubMedCrossRef Lam KY, Lo CY, Chan KW et al (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338PubMedCrossRef
218.
Zurück zum Zitat McIver B, Hay ID, Giuffrida DF et al (2001) Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130:1028–1034PubMedCrossRef McIver B, Hay ID, Giuffrida DF et al (2001) Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130:1028–1034PubMedCrossRef
219.
Zurück zum Zitat DeMeter JG, De Jong SA, Lawrence AM et al (2001) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956–961 DeMeter JG, De Jong SA, Lawrence AM et al (2001) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956–961
220.
Zurück zum Zitat Lang BH, Lo CY (2007) Surgical options in undifferentiated thyroid carcinoma. World J Surg 31:969–977PubMedCrossRef Lang BH, Lo CY (2007) Surgical options in undifferentiated thyroid carcinoma. World J Surg 31:969–977PubMedCrossRef
221.
Zurück zum Zitat Haigh PI, Ituarte PHG, Wu HS et al (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335–2342PubMedCrossRef Haigh PI, Ituarte PHG, Wu HS et al (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335–2342PubMedCrossRef
222.
Zurück zum Zitat Sugino K, Ito K, Mimura T, et al. (2002) The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245–248 Sugino K, Ito K, Mimura T, et al. (2002) The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245–248
223.
Zurück zum Zitat Kebebew E, Greenspan FS, Clark OH et al (2005) Anaplastic thyroid carcinoma: treatment outcomes and prognostic factos. Cancer 103:1330–1335PubMedCrossRef Kebebew E, Greenspan FS, Clark OH et al (2005) Anaplastic thyroid carcinoma: treatment outcomes and prognostic factos. Cancer 103:1330–1335PubMedCrossRef
224.
Zurück zum Zitat Miccoli P, Materazzi G, Antonelli A et al (2007) New trends in the treatment of undifferentiated carcinomas of the thyroid. Langenbeck’s Arch Surg 392:397–404CrossRef Miccoli P, Materazzi G, Antonelli A et al (2007) New trends in the treatment of undifferentiated carcinomas of the thyroid. Langenbeck’s Arch Surg 392:397–404CrossRef
225.
Zurück zum Zitat Besic N, Auersperg M, Us-Krasovec M et al (2001) Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 27:260–264PubMedCrossRef Besic N, Auersperg M, Us-Krasovec M et al (2001) Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 27:260–264PubMedCrossRef
226.
Zurück zum Zitat Pierie JP, Muzikansky A, Gaz RD et al (2002) The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57–62PubMedCrossRef Pierie JP, Muzikansky A, Gaz RD et al (2002) The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57–62PubMedCrossRef
227.
Zurück zum Zitat Tennvall J, Lundell G, Wahlberg P et al (2002) Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86:1848–1853PubMedCrossRef Tennvall J, Lundell G, Wahlberg P et al (2002) Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86:1848–1853PubMedCrossRef
228.
Zurück zum Zitat Troch M, Koperek O, Scheuba C et al (2010) High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. J Clin Endocrinol Metab 95:E54–57PubMedCrossRef Troch M, Koperek O, Scheuba C et al (2010) High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. J Clin Endocrinol Metab 95:E54–57PubMedCrossRef
229.
Zurück zum Zitat HigashiyamaT IY, Hirokawa M et al (2010) Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid 20:7–14CrossRef HigashiyamaT IY, Hirokawa M et al (2010) Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid 20:7–14CrossRef
230.
Zurück zum Zitat Mulligan LM, Kwok JBJ, Healey CS et al (1993) Germ-line mutations of the RET prot-oncogene in multiple endocrine neoplasia type 2a. Nature 363:458–460PubMedCrossRef Mulligan LM, Kwok JBJ, Healey CS et al (1993) Germ-line mutations of the RET prot-oncogene in multiple endocrine neoplasia type 2a. Nature 363:458–460PubMedCrossRef
231.
Zurück zum Zitat Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2a and FMTC. Hum Mol Genet 7:851–856CrossRef Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2a and FMTC. Hum Mol Genet 7:851–856CrossRef
232.
Zurück zum Zitat Frank-Raue K, Machens A, Leidig-Bruckner et al (2013) Prevalence and clinical spectrum of “nonsecretory” medullary thyroid carcinoma in a series of eight hundred thirty-nine patients with sporadic medullary thyroid carcinoma. Thyroid. doi:10.1089/thy.2012.0236 Frank-Raue K, Machens A, Leidig-Bruckner et al (2013) Prevalence and clinical spectrum of “nonsecretory” medullary thyroid carcinoma in a series of eight hundred thirty-nine patients with sporadic medullary thyroid carcinoma. Thyroid. doi:10.​1089/​thy.​2012.​0236
233.
Zurück zum Zitat Machens A, Schneyer U, Holzhausen HJ et al (2005) Propects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029–2034PubMedCrossRef Machens A, Schneyer U, Holzhausen HJ et al (2005) Propects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029–2034PubMedCrossRef
234.
Zurück zum Zitat Machens A, Dralle H (2012) Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab 97:1547–1553PubMedCrossRef Machens A, Dralle H (2012) Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab 97:1547–1553PubMedCrossRef
235.
Zurück zum Zitat Schilling T, Burck J, Sinn HP et al (2001) Prognostic value of codon 918 (ATG-ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer 95:62–66PubMedCrossRef Schilling T, Burck J, Sinn HP et al (2001) Prognostic value of codon 918 (ATG-ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer 95:62–66PubMedCrossRef
236.
Zurück zum Zitat Elisei R, Cosci B, Romei C et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682–687PubMedCrossRef Elisei R, Cosci B, Romei C et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682–687PubMedCrossRef
237.
Zurück zum Zitat Romei C, Ugolini C, Cosci B et al (2012) Low prevalence of the somatic M918T Ret mutation in micro-medullary thyroid cancer. Thyroid 5:476–481CrossRef Romei C, Ugolini C, Cosci B et al (2012) Low prevalence of the somatic M918T Ret mutation in micro-medullary thyroid cancer. Thyroid 5:476–481CrossRef
238.
Zurück zum Zitat Miyauchi A, Onishi T, Morimoto S et al (1984) Relation of doubling time of plasma calitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 199:461–466PubMedCrossRef Miyauchi A, Onishi T, Morimoto S et al (1984) Relation of doubling time of plasma calitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 199:461–466PubMedCrossRef
239.
Zurück zum Zitat Cohen R, Campos JM, Salaun C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d’Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919–922PubMedCrossRef Cohen R, Campos JM, Salaun C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d’Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919–922PubMedCrossRef
240.
Zurück zum Zitat Barbet J, Chamion L, Kraeber-Bodere F et al (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084PubMedCrossRef Barbet J, Chamion L, Kraeber-Bodere F et al (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084PubMedCrossRef
241.
Zurück zum Zitat Machens A, Ukkat J, Hauptmann S et al (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression. Arch Surg 142:289–293PubMedCrossRef Machens A, Ukkat J, Hauptmann S et al (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression. Arch Surg 142:289–293PubMedCrossRef
242.
Zurück zum Zitat Machens A, Hauptmann S, Dralle H (2008) Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endorinol Metab 93:2234–2238CrossRef Machens A, Hauptmann S, Dralle H (2008) Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endorinol Metab 93:2234–2238CrossRef
243.
Zurück zum Zitat Machens A, Dralle H (2010) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655–2663PubMedCrossRef Machens A, Dralle H (2010) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655–2663PubMedCrossRef
244.
Zurück zum Zitat Machens A, Dralle H (2010) Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995–2009. Eur J Endocrinol 163:111–119PubMedCrossRef Machens A, Dralle H (2010) Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995–2009. Eur J Endocrinol 163:111–119PubMedCrossRef
245.
Zurück zum Zitat Vierhapper H, Niederle B, Bieglmayer C et al (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267–1272PubMedCrossRef Vierhapper H, Niederle B, Bieglmayer C et al (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267–1272PubMedCrossRef
246.
Zurück zum Zitat Herrmann BL, Schmid KW, Goerges R et al (2010) Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol 162:1141–1145PubMedCrossRef Herrmann BL, Schmid KW, Goerges R et al (2010) Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol 162:1141–1145PubMedCrossRef
247.
Zurück zum Zitat Chambon G, Alovisetti C, Idoux-Louche C et al (2011) The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96:75–81PubMedCrossRef Chambon G, Alovisetti C, Idoux-Louche C et al (2011) The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96:75–81PubMedCrossRef
248.
Zurück zum Zitat Musholt TJ, Clerici T, Dralle H et al (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbeck’s Arch Surg 396:639–649CrossRef Musholt TJ, Clerici T, Dralle H et al (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbeck’s Arch Surg 396:639–649CrossRef
249.
Zurück zum Zitat Kratzsch J, Petzold A, Raue F et al (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57:467–474PubMedCrossRef Kratzsch J, Petzold A, Raue F et al (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57:467–474PubMedCrossRef
250.
Zurück zum Zitat Basuyau JP, Mallet E, Leroy M et al (2004) Reference intervals for serum calcitonin in men, women, and children. Clin Chem 50:1828–1830PubMedCrossRef Basuyau JP, Mallet E, Leroy M et al (2004) Reference intervals for serum calcitonin in men, women, and children. Clin Chem 50:1828–1830PubMedCrossRef
251.
Zurück zum Zitat Verga U, Morpurgo PS, Vaghi I et al (2006) Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay. Horm Res 66:17–20PubMedCrossRef Verga U, Morpurgo PS, Vaghi I et al (2006) Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay. Horm Res 66:17–20PubMedCrossRef
252.
Zurück zum Zitat Machens A, Haedecke J, Holzhausen HJ et al (2000) Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbeck’s Arch Surg 385:398–401CrossRef Machens A, Haedecke J, Holzhausen HJ et al (2000) Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbeck’s Arch Surg 385:398–401CrossRef
253.
Zurück zum Zitat Machens A, Haedicke J, Hinze R et al (2000) Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail. Dig Surg 17:522–524PubMedCrossRef Machens A, Haedicke J, Hinze R et al (2000) Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail. Dig Surg 17:522–524PubMedCrossRef
254.
Zurück zum Zitat Schneider R, Waldmann J, Swaid Z et al (2011) Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 40:213–221PubMedCrossRef Schneider R, Waldmann J, Swaid Z et al (2011) Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 40:213–221PubMedCrossRef
255.
Zurück zum Zitat Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960–1965PubMedCrossRef Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960–1965PubMedCrossRef
256.
Zurück zum Zitat Miyauchi A, Matsuzuka F, Hirai K et al (2002) Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg 26:1023–1028PubMedCrossRef Miyauchi A, Matsuzuka F, Hirai K et al (2002) Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg 26:1023–1028PubMedCrossRef
257.
Zurück zum Zitat Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887PubMedCrossRef Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887PubMedCrossRef
258.
Zurück zum Zitat Fleming JB, Lee JE, Bouvet M et al (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230:697–707PubMedCrossRef Fleming JB, Lee JE, Bouvet M et al (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230:697–707PubMedCrossRef
259.
Zurück zum Zitat Weber T, Schilling T, Frank-Raue K et al (2001) Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 130:1044–1049PubMedCrossRef Weber T, Schilling T, Frank-Raue K et al (2001) Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 130:1044–1049PubMedCrossRef
260.
Zurück zum Zitat Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075PubMedCrossRef Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075PubMedCrossRef
261.
Zurück zum Zitat Cupisti K, Wolf A, Raffel A et al (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma. Ann Surg 246:815–821PubMedCrossRef Cupisti K, Wolf A, Raffel A et al (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma. Ann Surg 246:815–821PubMedCrossRef
262.
Zurück zum Zitat Moley JF, Fialkowski EA (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg 31:946–956PubMedCrossRef Moley JF, Fialkowski EA (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg 31:946–956PubMedCrossRef
263.
Zurück zum Zitat van Heerden J, Grant CS, Gharib H et al (1990) Long-term course of patients with persistent hypercalitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395–401PubMedCrossRef van Heerden J, Grant CS, Gharib H et al (1990) Long-term course of patients with persistent hypercalitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395–401PubMedCrossRef
264.
Zurück zum Zitat Miyauchi A, Matsuzuka F, Kuma K et al (1988) Evaluation of surgical results and prediction of prognosis in patient with medullary thyroid carcinoma by analysis of serum calcitonin levels. World J Surg 12:610–615PubMedCrossRef Miyauchi A, Matsuzuka F, Kuma K et al (1988) Evaluation of surgical results and prediction of prognosis in patient with medullary thyroid carcinoma by analysis of serum calcitonin levels. World J Surg 12:610–615PubMedCrossRef
265.
Zurück zum Zitat Machens A, Dralle H (2013) Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Ann Surg 257:323–329PubMedCrossRef Machens A, Dralle H (2013) Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Ann Surg 257:323–329PubMedCrossRef
266.
Zurück zum Zitat Dralle H, Machens A (2013) Surgical management of the lateral neck compartment for metastatic thyroid cancer. Curr Opin Oncol 25:20–26PubMedCrossRef Dralle H, Machens A (2013) Surgical management of the lateral neck compartment for metastatic thyroid cancer. Curr Opin Oncol 25:20–26PubMedCrossRef
267.
Zurück zum Zitat Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671PubMedCrossRef Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671PubMedCrossRef
268.
Zurück zum Zitat Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1523PubMedCrossRef Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1523PubMedCrossRef
269.
Zurück zum Zitat Machens A, Brauckhoff M, Holzhausen H et al (2005) Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 90:3999–4003PubMedCrossRef Machens A, Brauckhoff M, Holzhausen H et al (2005) Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 90:3999–4003PubMedCrossRef
270.
Zurück zum Zitat Lips C, Landsvater RM, Höppener J et al (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331:828–835PubMedCrossRef Lips C, Landsvater RM, Höppener J et al (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331:828–835PubMedCrossRef
271.
Zurück zum Zitat Wells SA, Chi DD, Toshima K et al (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 200:237–250CrossRef Wells SA, Chi DD, Toshima K et al (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 200:237–250CrossRef
272.
Zurück zum Zitat Dralle H, Gimm O, Simon D et al (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–750PubMedCrossRef Dralle H, Gimm O, Simon D et al (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–750PubMedCrossRef
273.
Zurück zum Zitat Machens A, Dralle H (2009) Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer. Thyroid 19:551–554PubMedCrossRef Machens A, Dralle H (2009) Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer. Thyroid 19:551–554PubMedCrossRef
274.
Zurück zum Zitat Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer. Ann Surg 250:305–310PubMedCrossRef Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer. Ann Surg 250:305–310PubMedCrossRef
275.
Zurück zum Zitat Elisei R, Romei C, Renzini G et al (2012) The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab 97:426–435PubMedCrossRef Elisei R, Romei C, Renzini G et al (2012) The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab 97:426–435PubMedCrossRef
276.
Zurück zum Zitat Skinner MA, Moley JA, Dilley WG et al (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353:1105–1113PubMedCrossRef Skinner MA, Moley JA, Dilley WG et al (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353:1105–1113PubMedCrossRef
277.
Zurück zum Zitat Brauckhoff M, Gimm O, Weiss CL et al (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305–1311PubMedCrossRef Brauckhoff M, Gimm O, Weiss CL et al (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305–1311PubMedCrossRef
278.
Zurück zum Zitat Brauckhoff M, Machens A, Hess S et al (2008) Premonitory symptoms preceding metastatic medullary thryoid cancer in MEN 2B: an exploratory analysis. Surgery 144:1044–1051PubMedCrossRef Brauckhoff M, Machens A, Hess S et al (2008) Premonitory symptoms preceding metastatic medullary thryoid cancer in MEN 2B: an exploratory analysis. Surgery 144:1044–1051PubMedCrossRef
279.
Zurück zum Zitat Roman S, Lin R, Sosa JA (2006) Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107:2134–2142PubMedCrossRef Roman S, Lin R, Sosa JA (2006) Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107:2134–2142PubMedCrossRef
280.
Zurück zum Zitat Raffel A, Cupisti K, Krausch M et al (2004) Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 28:397–401PubMedCrossRef Raffel A, Cupisti K, Krausch M et al (2004) Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 28:397–401PubMedCrossRef
281.
Zurück zum Zitat Franc S, Niccoli-Sire P, Cohen R et al (2001) Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol 55:403–409CrossRef Franc S, Niccoli-Sire P, Cohen R et al (2001) Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol 55:403–409CrossRef
282.
Zurück zum Zitat Tisell LE, Hansson G, Jansson S et al (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60–66PubMed Tisell LE, Hansson G, Jansson S et al (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60–66PubMed
283.
Zurück zum Zitat Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 122:1124–1130PubMedCrossRef Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 122:1124–1130PubMedCrossRef
284.
Zurück zum Zitat Kebebew E, Kikuchi S, Duh QY et al (2000) Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg 135:895–901PubMedCrossRef Kebebew E, Kikuchi S, Duh QY et al (2000) Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg 135:895–901PubMedCrossRef
285.
Zurück zum Zitat Fernandez Vila JM, Peix JL, Mandry AC, Mezzadri NA, Lifante JC (2007) Biochemical results of reoperations for medullary thyroid carcinoma. Laryngoscope 117:886–889PubMedCrossRef Fernandez Vila JM, Peix JL, Mandry AC, Mezzadri NA, Lifante JC (2007) Biochemical results of reoperations for medullary thyroid carcinoma. Laryngoscope 117:886–889PubMedCrossRef
286.
Zurück zum Zitat Fialkowski E, DeBenedetti M, Moley J (2008) Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg 32:754–765PubMedCrossRef Fialkowski E, DeBenedetti M, Moley J (2008) Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg 32:754–765PubMedCrossRef
288.
Zurück zum Zitat Schlumberger M, Basthold L, Dralle H et al (2012) 2012 European thyroid association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14CrossRef Schlumberger M, Basthold L, Dralle H et al (2012) 2012 European thyroid association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14CrossRef
289.
Zurück zum Zitat Lorenz K, Brauckhoff M, Behrmann C et al (2005) Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. Surgery 138:986–993PubMedCrossRef Lorenz K, Brauckhoff M, Behrmann C et al (2005) Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. Surgery 138:986–993PubMedCrossRef
290.
Zurück zum Zitat Fromigue J, De Baere T, Baudin E et al (2006) Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab 91:2496–2499PubMedCrossRef Fromigue J, De Baere T, Baudin E et al (2006) Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab 91:2496–2499PubMedCrossRef
291.
Zurück zum Zitat Schuffenecker I, Virally-Monod M, Brohet R et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 83:487–491PubMedCrossRef Schuffenecker I, Virally-Monod M, Brohet R et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 83:487–491PubMedCrossRef
292.
Zurück zum Zitat Mack LA, Pasieka JL (2007) An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 31:978–986PubMedCrossRef Mack LA, Pasieka JL (2007) An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 31:978–986PubMedCrossRef
293.
Zurück zum Zitat Graff-Baker A, Roman SA, Thomas DC et al (2009) Prognosis of primary thyroid lymphoma. Surgery 146:1105–1115PubMedCrossRef Graff-Baker A, Roman SA, Thomas DC et al (2009) Prognosis of primary thyroid lymphoma. Surgery 146:1105–1115PubMedCrossRef
294.
Zurück zum Zitat Graff-Baker A, Sosa JA, Roman SA (2010) Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opinion Oncol 22:17–22CrossRef Graff-Baker A, Sosa JA, Roman SA (2010) Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opinion Oncol 22:17–22CrossRef
295.
Zurück zum Zitat Iyengar P, Mazloom A, Shihadeh F et al (2010) Hodgkin lymphoma involving extranodal and nodal head and neck sites. Cancer 116:3825–3829PubMedCrossRef Iyengar P, Mazloom A, Shihadeh F et al (2010) Hodgkin lymphoma involving extranodal and nodal head and neck sites. Cancer 116:3825–3829PubMedCrossRef
296.
Zurück zum Zitat Behringer K, Thomas RK, Pfreundschuh M, Diehl V, Wolf J (2006) Hodgkin-Lymphom (Morbus Hodgkin). In: Schmoll HJ, Höffken K, Possinger K (eds) Kompendium Internistische Onkologie, 4th edn. Springer, Heidelberg, pp 2777–2828, GermanCrossRef Behringer K, Thomas RK, Pfreundschuh M, Diehl V, Wolf J (2006) Hodgkin-Lymphom (Morbus Hodgkin). In: Schmoll HJ, Höffken K, Possinger K (eds) Kompendium Internistische Onkologie, 4th edn. Springer, Heidelberg, pp 2777–2828, GermanCrossRef
297.
Zurück zum Zitat Morgen EK, Geddie W, Boerner S et al (2010) The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series. J Clin Pathol 63:129–133PubMedCrossRef Morgen EK, Geddie W, Boerner S et al (2010) The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series. J Clin Pathol 63:129–133PubMedCrossRef
298.
Zurück zum Zitat Basu S, Li G, Bural G et al (2009) Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of the thyroid lymphoma and their potential clinical utility. Acta Radiol 50:201–204PubMedCrossRef Basu S, Li G, Bural G et al (2009) Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of the thyroid lymphoma and their potential clinical utility. Acta Radiol 50:201–204PubMedCrossRef
299.
Zurück zum Zitat Laing RW, Hoskin P, Hudson BV et al (1994) The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 6:300–304CrossRef Laing RW, Hoskin P, Hudson BV et al (1994) The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 6:300–304CrossRef
300.
Zurück zum Zitat Derringer GA, Thompson LDR, Frommelt RA et al (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24:623–639PubMedCrossRef Derringer GA, Thompson LDR, Frommelt RA et al (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24:623–639PubMedCrossRef
301.
Zurück zum Zitat Thieblemont C, Mayer A, Dumontet C et al (2002) Primary lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 87:105–111PubMedCrossRef Thieblemont C, Mayer A, Dumontet C et al (2002) Primary lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 87:105–111PubMedCrossRef
302.
Zurück zum Zitat Tsang RW, Gospodarowicz MK, Pintilie M et al (2003) Localized mucosa-associated lympoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21:4147–4164CrossRef Tsang RW, Gospodarowicz MK, Pintilie M et al (2003) Localized mucosa-associated lympoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21:4147–4164CrossRef
303.
Zurück zum Zitat Zelenetz AD, Advani RH, Buadi F et al (2006) Non-Hodgkin’s lymphoma. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 4:258–310 Zelenetz AD, Advani RH, Buadi F et al (2006) Non-Hodgkin’s lymphoma. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 4:258–310
304.
Zurück zum Zitat Weber DC, Peguret N, Dipasquale G et al (2009) Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. Int J Radiat Oncol Biol Phys 75:1578–1586PubMedCrossRef Weber DC, Peguret N, Dipasquale G et al (2009) Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. Int J Radiat Oncol Biol Phys 75:1578–1586PubMedCrossRef
305.
Zurück zum Zitat Matsuzuka F, Miyauchi A, Katayama S et al (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3:93–99PubMedCrossRef Matsuzuka F, Miyauchi A, Katayama S et al (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3:93–99PubMedCrossRef
306.
Zurück zum Zitat Sippel RS, Gauger PG, Angelos P et al (2002) Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 9:907–911PubMedCrossRef Sippel RS, Gauger PG, Angelos P et al (2002) Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 9:907–911PubMedCrossRef
307.
Zurück zum Zitat Joshi A, Chan J, Bruch G et al (2009) Thyroid lymphoma and airway obstruction—is there a rationale for surgical management? J Clin Pract 63:1647–1652CrossRef Joshi A, Chan J, Bruch G et al (2009) Thyroid lymphoma and airway obstruction—is there a rationale for surgical management? J Clin Pract 63:1647–1652CrossRef
308.
Zurück zum Zitat Jonak C, Troch M, Müllauer L et al (2010) Ritumximab plus dose-reduced cyclophosphamide, metoxantrone, vincristine and prednisolone are effective in elderly patients with diffuse large-cell B-cell lymphomas of the thyroid. Thyroid 20:425–427PubMedCrossRef Jonak C, Troch M, Müllauer L et al (2010) Ritumximab plus dose-reduced cyclophosphamide, metoxantrone, vincristine and prednisolone are effective in elderly patients with diffuse large-cell B-cell lymphomas of the thyroid. Thyroid 20:425–427PubMedCrossRef
309.
Zurück zum Zitat Lee J, Won JH, Kim HC et al (2009) Emergency dilation by self-expandable tracheal stent for upper airway obstruction in a patient with a giant primary thyroid lymphoma. Thyroid 19:193–195PubMedCrossRef Lee J, Won JH, Kim HC et al (2009) Emergency dilation by self-expandable tracheal stent for upper airway obstruction in a patient with a giant primary thyroid lymphoma. Thyroid 19:193–195PubMedCrossRef
310.
Zurück zum Zitat Mortensen JD, Woolner LB, Bennett WA (1956) Secondary malignant tumory of the thyroid gland. Cancer 9:306–310PubMedCrossRef Mortensen JD, Woolner LB, Bennett WA (1956) Secondary malignant tumory of the thyroid gland. Cancer 9:306–310PubMedCrossRef
311.
Zurück zum Zitat Shimaoka K, Sokal JE, Pickren JW (1962) Metastatic neoplasms in the thyroid gland. Pathological and clinical findings. Cancer 15:557–565PubMedCrossRef Shimaoka K, Sokal JE, Pickren JW (1962) Metastatic neoplasms in the thyroid gland. Pathological and clinical findings. Cancer 15:557–565PubMedCrossRef
312.
Zurück zum Zitat Berge T, Lundberg S (1977) Cancer in Malmo 1958 - 1969. An autopsy study. Acta Pathol Microbiol Scand Suppl (260)1:1–235 Berge T, Lundberg S (1977) Cancer in Malmo 1958 - 1969. An autopsy study. Acta Pathol Microbiol Scand Suppl (260)1:1–235
313.
Zurück zum Zitat Schröder S, Bürck CD, de Heer K (1987) Metastasen in der Schilddrüse - Morphologie und Klinik von 25 sekundären Schilddrüsengeschwülsten. Langenbecks Arch Chir 370:25–35, GermanPubMedCrossRef Schröder S, Bürck CD, de Heer K (1987) Metastasen in der Schilddrüse - Morphologie und Klinik von 25 sekundären Schilddrüsengeschwülsten. Langenbecks Arch Chir 370:25–35, GermanPubMedCrossRef
314.
Zurück zum Zitat Silverberg SG, Vidone RA (1966) Metastatic tumors in the thyroid. Pac Med Surg 74:175–185 Silverberg SG, Vidone RA (1966) Metastatic tumors in the thyroid. Pac Med Surg 74:175–185
315.
Zurück zum Zitat Haugen BR, Nawaz S, Cohn A et al (1994) Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid 4:297–300PubMedCrossRef Haugen BR, Nawaz S, Cohn A et al (1994) Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid 4:297–300PubMedCrossRef
316.
Zurück zum Zitat Nakhjavani MK, Gharib H, Goellner JR et al (1997) Metastasis to the thyroid gland. A report of 43 cases. Cancer 79:574–578PubMedCrossRef Nakhjavani MK, Gharib H, Goellner JR et al (1997) Metastasis to the thyroid gland. A report of 43 cases. Cancer 79:574–578PubMedCrossRef
317.
Zurück zum Zitat Mirallie E, Rigaud J, Mathonnet M et al (2005) Management and prognosis of metastases to the thyroid gland. J Am Coll Surg 200:203–207PubMedCrossRef Mirallie E, Rigaud J, Mathonnet M et al (2005) Management and prognosis of metastases to the thyroid gland. J Am Coll Surg 200:203–207PubMedCrossRef
318.
Zurück zum Zitat Lam KY, Lo CY (1998) Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med 122:37–41PubMed Lam KY, Lo CY (1998) Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med 122:37–41PubMed
319.
Zurück zum Zitat Heffess CS, Wenig BM, Thompson LD (2002) Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer 95:1869–1878PubMedCrossRef Heffess CS, Wenig BM, Thompson LD (2002) Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer 95:1869–1878PubMedCrossRef
320.
Zurück zum Zitat Miiji LO, Nguyen GK (2005) Metastatic melanoma of the thyroid mimicking a papillary carcinoma on fine needle aspiration. Diagn Cytopathol 32:374–376PubMedCrossRef Miiji LO, Nguyen GK (2005) Metastatic melanoma of the thyroid mimicking a papillary carcinoma on fine needle aspiration. Diagn Cytopathol 32:374–376PubMedCrossRef
321.
Zurück zum Zitat Wada N, Hirikawa S, Rino Y et al (2005) Solitary metachronous metastasis to the thyroid from renal clear cell carcinoma 19 years after nephrectomy. Surg Today 35:483–487PubMedCrossRef Wada N, Hirikawa S, Rino Y et al (2005) Solitary metachronous metastasis to the thyroid from renal clear cell carcinoma 19 years after nephrectomy. Surg Today 35:483–487PubMedCrossRef
322.
Zurück zum Zitat Sindoni A, Rizzo M, Tuccari G et al (2010) Thyroid metastases from renal cell carcinoma: review of the literature. Sci World J 10:590–602CrossRef Sindoni A, Rizzo M, Tuccari G et al (2010) Thyroid metastases from renal cell carcinoma: review of the literature. Sci World J 10:590–602CrossRef
323.
Zurück zum Zitat McCabe DP, Farrar WB, Petkov TM et al (1985) Clinical and pathological correlations in diseases metastatic to the thyroid gland. Am J Surg 150:519–523PubMedCrossRef McCabe DP, Farrar WB, Petkov TM et al (1985) Clinical and pathological correlations in diseases metastatic to the thyroid gland. Am J Surg 150:519–523PubMedCrossRef
324.
Zurück zum Zitat Kim TY, Kim WB, Gong G et al (2005) Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy. Clin Endocrinol 62:236–241CrossRef Kim TY, Kim WB, Gong G et al (2005) Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy. Clin Endocrinol 62:236–241CrossRef
325.
Zurück zum Zitat Benoit L, Favoulet P, Arnould L et al (2004) Metastatic renal cell carcinoma to the thyroid gland. Ann Chir 129:218–223PubMedCrossRef Benoit L, Favoulet P, Arnould L et al (2004) Metastatic renal cell carcinoma to the thyroid gland. Ann Chir 129:218–223PubMedCrossRef
326.
Zurück zum Zitat Iesalnieks I, Winter H, Bareck E et al (2008) Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18:615–624PubMedCrossRef Iesalnieks I, Winter H, Bareck E et al (2008) Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18:615–624PubMedCrossRef
327.
Zurück zum Zitat Machens A, Dralle H (2010) Outcome after thyroid surgery for metastasis from renal cell cancer. Surgery 147:65–71PubMedCrossRef Machens A, Dralle H (2010) Outcome after thyroid surgery for metastasis from renal cell cancer. Surgery 147:65–71PubMedCrossRef
328.
Zurück zum Zitat Brady LW, O'Neill EA, Farber SH (1977) Unusual sites of metastases. Semin Oncol 4:59–64PubMed Brady LW, O'Neill EA, Farber SH (1977) Unusual sites of metastases. Semin Oncol 4:59–64PubMed
329.
Zurück zum Zitat Blaloch ZN, Sack MJ, Yu GH et al (1999) Papillary formation in metastatic melanoma. Diagn Cytopathol 20:148–151CrossRef Blaloch ZN, Sack MJ, Yu GH et al (1999) Papillary formation in metastatic melanoma. Diagn Cytopathol 20:148–151CrossRef
Metadaten
Titel
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors
verfasst von
Henning Dralle
Thomas J. Musholt
Jochen Schabram
Thomas Steinmüller
Andreja Frilling
Dietmar Simon
Peter E. Goretzki
Bruno Niederle
Christian Scheuba
Thomas Clerici
Michael Hermann
Jochen Kußmann
Kerstin Lorenz
Christoph Nies
Peter Schabram
Arnold Trupka
Andreas Zielke
Wolfram Karges
Markus Luster
Kurt W. Schmid
Dirk Vordermark
Hans-Joachim Schmoll
Reinhard Mühlenberg
Otmar Schober
Harald Rimmele
Andreas Machens
for the German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V.
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2013
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-013-1057-6

Weitere Artikel der Ausgabe 3/2013

Langenbeck's Archives of Surgery 3/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.